Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wolfe Research Downgrades Adient to Peer Perform

Wolfe Research Downgrades Adient to Peer Perform

Wolfe Research analyst Rod Lache downgrades Adient (NYSE:ADNT) from Outperform to Peer Perform.

byBenzinga Newsdesk

February 9, 2023

1 minute read

Wolfe Research analyst Rod Lache downgrades Adient (NYSE:ADNT) from Outperform to Peer Perform.

Wells Fargo Maintains Equal-Weight on PacWest Banc, Raises Price Target to $28

By Benzinga Newsdesk

January 30, 8:51 AM

Wells Fargo analyst Steven Shaw maintains PacWest Banc (NASDAQ:PACW) with a Equal-Weight and raises the price target from $26 to $28.

PACW

Novo Nordisk’s Obesity Drug Saxenda Not Included In WHO’s Essential Drug List

By Vandana Singh

July 26, 10:24 AM

The World Health Organization (WHO) published the new editions of the Model Lists of Essential Medicines (EML) and Essen

MKGAF

Microsoft To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday

By Avi Kapoor

June 7, 8:26 AM

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

ADUS

Greenidge Generation’s 1-For-10 Reverse Stock Split Will Become Effective As Of 12:01 A.m. Eastern Time On May 16, 2023

By Happy Mohamed

May 16, 12:28 AM

The Company's Class A common stock will begin trading on a split-adjusted basis on May 16, 2023 FAIRFIELD, Conn., May 15, 2023 /PRNewswire/ -- Greenidge Generation Holdings Inc. (NASDAQ:GREE)

GREE

Wolfe Research Downgrades Adient to Peer Perform

Related Posts

Wells Fargo Maintains Equal-Weight on PacWest Banc, Raises Price Target to $28

Novo Nordisk’s Obesity Drug Saxenda Not Included In WHO’s Essential Drug List

Microsoft To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday

Greenidge Generation’s 1-For-10 Reverse Stock Split Will Become Effective As Of 12:01 A.m. Eastern Time On May 16, 2023